email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
496 - 510
of 3613 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
Next
Henlius Biotech Reports US Accepts Herceptin Biosimilar BLA for Review
$5.00
Available
Harbour BioMed Out-Licenses US Rights for Bispecific in $588 Million Deal
$5.00
Available
Clover Launches COVID-19 Vaccine in China as Second Booster Dose
$5.00
Available
CSPC Pharma Out-Licenses Nectin-4 ADC to Corbus in $692 Million Deal
$5.00
Available
Wondercell Closes $14 Million in Angel Funding for Immune Cell Therapies
$5.00
Available
Boan Biotech Starts China Trial of Anti-CD25 Antibody for Solid Tumor Cancers
$5.00
Available
CANbridge Acquires Global Rights to Rare Disease Therapy from UMass
$5.00
Available
ImmVira Posts Positive Data from Trial of Oncolytic Virus Injection for Melanoma
$5.00
Available
Technoderma Starts US Trial of JAK1/Tyk2 Inhibitor for Atopic Dermatitis
$5.00
Available
Asieris Collaborates with ReviR to Discover RNA Candidates for Genitourinary Tumors
$5.00
Available
China to Ban Export of Cutting-Edge Cell Therapy Technologies
$5.00
Available
Results from InnoCare’s BTK Lymphoma Trial Published in Hematology Journal
$5.00
Available
JiXing Buys Global Rights for Hypertension Candidate from PhaseBio
$5.00
Available
Structure Stages Expanded $161 Million IPO for Novel Small Molecules
$5.00
Available
Gracell Biotech to Start US Trial of Dual-Targeting CAR-T Therapy for Myeloma
$5.00
Available